Leaflet DANTRIUM IV 20mg powder for injection


Indicated for: spasticity; muscle spasms

Route of administration: injectable

Substance: dantrolen sodium (muscle relaxant)

ATC: M03CA01 (Musculo-skeletal system | Muscle relaxants, directly acting agents | Dantrolene and derivatives)

Dantrolen sodic is a medication used for the treatment of malignant hyperthermia and muscle spasticity associated with neurological conditions such as multiple sclerosis or spinal cord injuries. It works by reducing excessive muscle contractions, relaxing the muscles.

The medication is administered orally or intravenously, depending on the severity of the condition. It is effective in preventing and treating acute episodes of malignant hyperthermia, a rare but serious condition.

Side effects may include drowsiness, dizziness, muscle weakness, or nausea. In rare cases, liver toxicity or severe allergic reactions may occur. It is important to follow your doctor's instructions and monitor liver function during treatment.

Consult your doctor before use, especially if you have liver conditions or are taking other medications. Use Dantrolen sodic as directed to avoid complications.

General data about DANTRIUM IV 20mg

  • Substance: dantrolen sodium
  • Date of last drug list: 01-05-2025
  • Commercial code: W68769001
  • Concentration: 20mg
  • Pharmaceutical form: powder for injection
  • Quantity: 12
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: NORGINE B.V. - OLANDA
  • Holder: ALLIANCE HEALTHCARE ROMANIA S.R.L. - ROMANIA
  • Number: 708/2022/01